Axon Therapies Inc. — Form D
Axon Therapies Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-28. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-06-28
- Form: D
- Accession: 0001671158-17-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.3M
- Remaining: $700K
- Investors: 7
- Date of first sale: 2017-06-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-289607
Issuer
- Name: Axon Therapies Inc.
- CIK: 0001671158
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: C/O CORIDEA, LLC, NEW YORK, NY, 10018
- Phone: 212-929-6600
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Steven S Hochberg | Director | New York, NY |
| Paul S LaViolette | Director | Tewksbury, MA |
| Andrew S ElBardissi | Director | Milford, MA |
| Mitchell S Bloom | Executive Officer | New York, NY |
| Mark R Gelfand | Director | New York, NY |
| Mark R Gelfand | Executive Officer | New York, NY |
| Howard R Levin | Director | New York, NY |
| Howard R Levin | Executive Officer | New York, NY |
| Imran S Eba | Director | New York, NY |
Other filings by this issuer (3)
More